Biofrontera Inc.

Historical 13F Holders

Symbol
BFRI
CUSIP
09077D209
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 09077D209 since 12/18/2024, newest first.

Filer % of Class Filed
Rosalind Advisors, Inc. 13G/A Amendment 9
9.9% 8/12/2026
Event 6/30/2026
Rosalind Advisors, Inc. 13G/A Amendment 8
9.9% 2/11/2026
Event 12/31/2025
Orin Hirschman 13G/A Amendment 2
7.9% 1/28/2026
Event 12/31/2025
Rosalind Advisors, Inc. 13G/A Amendment 7
9.9% 11/12/2025
Event 10/27/2025
Deutsche Balaton Aktiengesellschaft 13D/A Amendment 4
20.0% 9/19/2025
Event 9/16/2025
Rosalind Advisors, Inc. 13G/A Amendment 6
9.9% 8/11/2025
Event 6/30/2025
Deutsche Balaton Aktiengesellschaft 13D/A Amendment 3
4.9% 7/25/2025
Event 6/30/2025
Lytton Laurence W 13G/A Amendment 2 3.5% 5/15/2025
Event 3/31/2025
Rosalind Advisors, Inc. 13G/A Amendment 5
9.9% 5/13/2025
Event 3/31/2025
Rosalind Advisors, Inc. 13G/A Amendment 4
9.9% 2/12/2025
Event 12/31/2024
Orin Hirschman 13G/A Amendment 1
9.9% 1/29/2025
Event 12/31/2024
Deutsche Balaton Aktiengesellschaft 13D/A Amendment 2
5.9% 12/20/2024
Event 12/20/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 19 2.76 M $2.61 M
2026 Q1 12 2.39 M $1.94 M
2025 Q4 14 2.34 M $1.33 M
2025 Q3 13 2.42 M $2.39 M
2025 Q2 11 2.04 M $1.45 M
2025 Q1 13 1.48 M $1.18 M
2024 Q4 15 1.81 M $1.97 M
2024 Q3 10 1.07 M $1.43 M
2024 Q2 14 1.17 M $1.05 M
2024 Q1 12 1.09 M $1.67 M
2023 Q4 11 10.5 k $29.0 k
2023 Q3 8 16.2 k $142 k